

Toll-Free: (800) 266-7207  For Domestic | Intl: (404) 496-4049

  • Follow
  • Follow
  • Follow

Invest Now

  • Home
  • About Us
    • Our Tribe
    • Our Mission
    • Our Values
    • Our Future
  • Medical & Wellness Testing
  • Wound Care
  • Contact Us
  • News
  • Invest Now
  • Home
  • About Us
    • Our Tribe
    • Our Mission
    • Our Values
    • Our Future
  • Contact Us
  • Medical & Wellness Testing
  • Wound Care
  • News
  • Invest Now
AI Medical Ethics: Safeguarding Your Genomic Code

AI Medical Ethics: Safeguarding Your Genomic Code

Mar 6, 2024 | AI Ethics Healthcare | 0 comments

Artificial intelligence (AI) presents a groundbreaking frontier in healthcare, offering unprecedented capabilities in analyzing vast datasets, including our own genomic code. This potent blend of genomics and AI has the potential to unlock personalized medicine,...
Revolutionary AI Predicts Alzheimer’s 7 Years Early: A UCSF Breakthrough

Revolutionary AI Predicts Alzheimer’s 7 Years Early: A UCSF Breakthrough

Mar 4, 2024 | Health, News | 0 comments

  Researchers at the University of California, San Francisco, have achieved a medical milestone by using artificial intelligence to predict Alzheimer’s disease up to seven years before symptoms appear. Published in Nature Aging on February 21, 2024, the study...
Toxicology Drug Screening Market Towards a $70.8 Billion Valuation by 2033

Toxicology Drug Screening Market Towards a $70.8 Billion Valuation by 2033

Feb 26, 2024 | Health, News | 0 comments

The market for global toxicology drug screening is projected to witness significant growth, with expectations to reach a value of approximately $70.80 billion by 2033, as per insights from a recent market analysis. This growth trajectory represents a notable increase...
The Hidden Danger in the Air: How Fine Particulate Matter is Impacting Our Health

The Hidden Danger in the Air: How Fine Particulate Matter is Impacting Our Health

Feb 22, 2024 | Health, News | 0 comments

Recent studies in the United States have uncovered a worrying link between both short-term and long-term exposure to fine particulate matter (PM2.5) and a heightened risk of hospital admissions for serious heart and lung diseases. Published in The BMJ, these findings...
The Importance of Prompt Detection in Combating Childhood Cancer

The Importance of Prompt Detection in Combating Childhood Cancer

Feb 20, 2024 | Health, News | 0 comments

Experts agree that prompt detection plays a pivotal role in combatting childhood cancer. Identifying cancer in its initial stages not only boosts the effectiveness of treatment but also enhances the chances of a longer, healthier life for young patients. In India,...
« Older Entries
Next Entries »

Recent Posts

  • CMS Confirms Government-to-Government Receipt of Tribal Real-World Evidence Submission for Rampart™ DL Matrix
  • Tribal Consortium Commences Sovereign Enforcement Activity to Protect Tribal Authority Over the Rampart™ Product Line
  • CMS Federal Register Identifies Rampart™ DL Matrix as Tribally Owned in CY 2026 Medicare Physician Fee Schedule Policy Update
  • Tribal Consortium Issues Sovereign Notice to CMS Requesting Formal Recognition of Tribal Ownership of Q4347
  • CMS Coverage and Analysis Group Confirms Receipt of Tribal Real-World Evidence Submission

Recent Comments

No comments to show.

ABOUT US

Clear Health Pass™ Clear Health Pass Holdings, LLC (“CHP”) serves as an authorized Tribal Agent for a multi-tribal economic development and sovereign innovation initiative, pursuant to written delegations issued by federally recognized Tribal economic development corporations organized under Section 16 / Section 17 of the Indian Reorganization Act (25 U.S.C. sections 5123-5124).

(800) 266-7207
(404) 496-4049

 

 

 

OUR TESTS

  • Clear Health Pass MDHeartPro
  • Clear Health Pass MDDiabeticPro
  • Clear Health Pass MDGeneticPro Women’s Health
  • Clear Health Pass MDAllergyPro
  • Clear Health Pass MDDrugPro
  • Clear Health Pass NIPT

OUR PARTNERS

Under Disclaimers & Regulatory Disclosures

 

    • Use of Artificial Intelligence (AI)
    • CLIA Certification and Laboratory Accreditation
    • HIPAA Compliance and Data Security
    • FDA Compliance for Laboratory-Developed Tests 
    • Tribal Sovereignty and Compliance
    • Medical Disclaimer for Lab Testing & Result Interpretation
    • Quality Assurance Commitment
    • Third-Party Vendor Compliance
    • Safe Harbor Statement
    • Privacy Policy | Terms and Conditions

 

© 2022-2025 Clear Health Pass Holdings, LLC. All rights reserved. Clear Health Pass, DrugPro, GeneticPro, DiabeticPro, and HeartPro are trademarks of Clear Health Pass Holdings, LLC. Unauthorized use of these trademarks is strictly prohibited.